Technology
Health
Biotechnology

NuCana

$15.52
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.98 (-5.94%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell NuCana and other stocks, options, ETFs, and crypto commission-free!

About

NuCana Plc engages in the development of technology platform for the treatment of patients with cancer. Its Protide technology is consists of acelarin, NUC-3373, and NUC-7738. Read More The company was founded by Hugh S. Griffith and Christopher B. Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.

Employees
24
Headquarters
Edinburgh, Midlothian
Founded
1997
Market Cap
492.39M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
62.58K
High Today
$17.11
Low Today
$15.26
Open Price
$16.66
Volume
24.94K
52 Week High
$32.00
52 Week Low
$10.37

Collections

Technology
Health
Biotechnology
Medical
Cancer Prevention
Biopharmaceutical
Pharmaceutical
2017 IPO

Earnings

-$21.52
-$14.36
-$7.21
-$0.05
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$19.05 per share
Actual
-$0.14 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.